Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 927.03% | -15.23% | -23.54% | 71.14% | -64.72% |
| Total Receivables | 32.11% | -13.27% | 42.64% | 20.09% | 55.28% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 105.00% | 177.97% | 548.19% | 308.76% | 222.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 824.16% | -6.91% | -21.01% | 73.90% | -60.39% |
|
|
|||||
| Total Current Assets | 824.16% | -6.91% | -21.01% | 73.90% | -60.39% |
| Net Property, Plant & Equipment | 86.55% | 54.50% | 31.72% | -6.86% | 7.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 430.43% | 1,591.30% | 1,332.14% | 1,071.01% | 493.55% |
| Total Assets | 790.98% | -5.52% | -20.21% | 72.42% | -59.18% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 63.18% | 31.20% | -46.12% | -22.14% | -12.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.43% | -99.24% | -99.45% | -99.31% | -99.31% |
| Total Finance Division Other Current Liabilities | 26.01% | -99.43% | -99.11% | -99.59% | -91.21% |
| Total Other Current Liabilities | 26.01% | -99.43% | -99.11% | -99.59% | -91.21% |
| Total Current Liabilities | 60.62% | -77.43% | -88.13% | -83.98% | -83.35% |
|
|
|||||
| Total Current Liabilities | 60.62% | -77.43% | -88.13% | -83.98% | -83.35% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 560.84% | -- | -- | -- | 64.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 63.62% | -77.50% | -88.13% | -83.98% | -83.26% |
|
|
|||||
| Common Stock & APIC | 57.93% | 3.58% | 3.71% | 23.94% | 31.47% |
| Retained Earnings | -23.79% | -24.63% | -23.51% | -24.17% | -36.15% |
| Treasury Stock & Other | -17.94% | 4.51% | -50.51% | -53.72% | -- |
| Total Common Equity | 512.62% | -161.69% | -115.87% | -23.31% | -24.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 512.62% | -161.69% | -115.87% | -23.31% | -24.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.78% | -5.54% | -9.23% | -18.27% | -5.28% |
| Total Equity | 1,008.61% | 57.28% | 49.30% | 3,468.19% | -28.35% |
|
|
|||||